Skip Navigation

Publication Detail

Title: Enhanced cholesterol efflux to HDL through the ABCA1 transporter in hypertriglyceridemia of type 2 diabetes.

Authors: Yassine, Hussein N; Belopolskaya, Alexandra; Schall, Christina; Stump, Craig S; Lau, Serrine S; Reaven, Peter D

Published In Metabolism, (2014 May)

Abstract: Our objective was to examine the role of hypertriglyceridemia on the capacity of HDL to facilitate ABCA-1 mediated cholesterol efflux in type 2 diabetes (T2DM).HDL mediated cholesterol efflux through the ABCA-1 transporter was measured using BHK cell lines in samples of 71 participants with T2DM in the presence or absence of high triglyceride levels (TG). Additionally, HDL mediated efflux was measured in 13 diabetic and non-diabetic participants fasting and four hours after a high-fat test challenge.HDL mediated cholesterol efflux function was increased in participants with T2DM with hypertriglyceridemia when compared to participants with T2DM without hypertriglyceridemia (efflux ratio mean±standard deviation (SD), T2DM+TG: 1.17±0.25 vs. T2DM - TG: 1.03±0.19, p=0.0098). In the fat challenge study, we observed a significant increase in ABCA-1 mediated cholesterol efflux capacity following an ingestion of high-fat test meal by participants in both groups of T2DM (n=6, efflux ratio, mean±SD, pre: 0.86±0.4 vs. post: 1.34±0.6, p=0.01) and non-diabetic participants (n=7, efflux ratio mean±SD pre: 1.24±0.31 vs. post: 1.39±0.42, p=0.04) that was partly explained by the difference in CETP activity (r=0.6, p=0.03).Our study suggests that high triglyceride levels facilitate ABCA-1 mediated efflux function of HDL in part by activating CETP.

PubMed ID: 24636347 Exiting the NIEHS site

MeSH Terms: ATP Binding Cassette Transporter 1/metabolism; ATP Binding Cassette Transporter 1/physiology*; Aged; Animals; Biological Transport; Cells, Cultured; Cholesterol Ester Transfer Proteins/metabolism; Cholesterol/metabolism*; Cricetinae; Cross-Sectional Studies; Diabetes Mellitus, Type 2/complications; Diabetes Mellitus, Type 2/metabolism*; Female; Humans; Hypertriglyceridemia/etiology; Hypertriglyceridemia/metabolism*; Lipoproteins, HDL/metabolism*; Male; Middle Aged

Back
to Top